Toward the prevention and treatment of cerebral palsy through genetic and epigenetic modulation
|Funding from Vinnova||SEK 2 918 182|
|Project duration||January 2016 - September 2019|
Purpose and goal
The main purpose of this project is to identify CP-related genes and biomarkers and to develop methods for early screening of high-risk infants and early intervention to reduce the incidence of CP. We have identified CP-causative genes through whole-exosome sequencing and biomarkers through multi-omics analysis. This first-stage work has reached goal of the project, and further functional tests and validation are ongoing through collaborative work.
Expected results and effects
This project has achieved progress by 1) promoting the career development for the project leader, 2) identifying new genes for CP, and 3) establishing new international collaborations. The results of the project will promote academic development in the field of perinatal brain injury and CP in Gothenburg and in Sweden, and further application of the results will reduce the incidence of CP, which represents a large burden on the individuals, their families, and society.
Planned approach and implementation
This research seeks to identify causative genes or biomarkers of perinatal brain injury and CP in order to develop methods for early screening of high-risk infants and for preventing or reducing the incidence of CP. The collaboration promotes not only high-quality scientific research, but also the translation from basic research to clinically useful techniques that will ultimately benefit patients who otherwise might suffer from life-long handicaps.